WASHINGTON (dpa-AFX) - Synta Pharmaceuticals Corp. (SNTA) announced that
Chen Schor, Executive Vice President, Chief Operating Officer, has been named
President, Chief Executive Officer and a Director of the company, effective May
7, 2015. Schor...
NEW YORK (TheStreet) -- Shares of Synta Pharmaceuticals
rose 6.55% to $3.09 in late morning trading Thursday after the company announced presentations at the upcoming annual meeting of the American Association of Cancer Research.
Canaccord Genuity initiated coverage on Synta Pharmaceuticals Corp (NASDAQ: SNTA) with a Outperform rating.
Synta Pharmaceuticals shares have dropped 43.89% over the past 52 weeks, while the S&P 500 index has gained 15.17% in the same period....
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Synta Pharmaceuticals (SNTA):